These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1693353)

  • 1. Anticoagulant and antithrombotic effects of chemically modified heparins and pentosanpolysulfate.
    Krupinski K; Breddin HK; Casu B
    Haemostasis; 1990; 20(2):81-92. PubMed ID: 1693353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vessels.
    Weichert W; Breddin HK
    Haemostasis; 1988; 18 Suppl 3():55-63. PubMed ID: 2840375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model.
    Giedrojć J; Klimiuk M; Radziwon P; Kłoczko J; Bielawiec M; Breddin HK
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):340-5. PubMed ID: 10470990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic properties of heparin independent of its anticoagulant activity].
    Krupiński K; Bielawiec M; Breddin HK
    Acta Haematol Pol; 1994; 25(3):243-51. PubMed ID: 7992597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
    Giedrojc J; Breddin HK
    Thromb Res; 1991 Jul; 63(1):99-110. PubMed ID: 1948825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphate.
    Giedrojć J; Radziwon P; Klimiuk M; Bielawiec M; Breddin HK; Kłoczko J
    J Physiol Pharmacol; 1999 Mar; 50(1):111-9. PubMed ID: 10210159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
    Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant and antithrombotic properties of synthetic sulfated bis-lactobionic acid amides.
    Raake W; Klauser RJ; Elling H; Meinetsberger E
    Thromb Res; 1989 Dec; 56(6):719-30. PubMed ID: 2561233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
    Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J; Ofosu F; Buchanan M
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro.
    Johann S; Zoller C; Haas S; Blümel G; Lipp M; Förster R
    Thromb Haemost; 1995 Oct; 74(4):998-1002. PubMed ID: 8560445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
    Stevenson JL; Choi SH; Varki A
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7003-11. PubMed ID: 16203794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the biological effects of low-molecular-weight heparins.
    Bender N; Seidl C; Weichert W; Breddin HK
    Haemostasis; 1988; 18 Suppl 3():23-32. PubMed ID: 2840371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of sodium pentosanpolysulfate and unfractionated heparin on venous thrombosis; an experimental study in rats.
    Kiesel J; Harbauer G; Wenzel E; Pindur G; Bohnerth S
    Thromb Res; 1991 Nov; 64(3):301-8. PubMed ID: 1725226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on the low molecular weight heparin derivative CY 216.
    Kaiser B; Kühnemuth G; Markwardt F
    Pharmazie; 1990 Jul; 45(7):522-4. PubMed ID: 2173004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic activity and its relationship to in vitro anticoagulant effects.
    Gray E; Padilla A; Barrowcliffe TW
    Haemostasis; 1993 Mar; 23 Suppl 1():99-102. PubMed ID: 8388358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis].
    Krupiński K; Breddin HK; Bielawiec M; Płonowski A
    Kardiol Pol; 1992 Mar; 36(3):142-5. PubMed ID: 1318982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
    Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and antiheparin activities of a pentosan polysulphate.
    Scully MF; Weerasinghe KM; Ellis V; Djazaeri B; Kakkar VV
    Thromb Res; 1983 Jul; 31(1):87-97. PubMed ID: 6193602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.